SARO vs OSCR
Comparison between StandardAero Inc (SARO, Company) and Oscar Health Inc - Class A (OSCR, Company).
SARO is from the Industrials sector, while OSCR is from the Healthcare sector.
SARO vs OSCR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
SARO
$9.15B
OSCR
$9.13B
Max Drawdown
Winner
SARO
32.58%
OSCR
94.15%
Sharpe Ratio
SARO
-0.23
Winner
OSCR
1.29
5Y Beta
SARO
1.13
Winner
OSCR
1.05
Industry
SARO
Aerospace & Defense
OSCR
Healthcare Plans
P/E Ratio
SARO
31.23
Winner
OSCR
15.71
Forward P/E
Winner
SARO
19.42
OSCR
588.24
PEG Ratio
SARO
0.11
Winner
OSCR
0.05
Debt to Equity
SARO
82.16%
Winner
OSCR
25.90%
Free Cash Flow Yield
SARO
1.62%
Winner
OSCR
31.06%
SARO vs OSCR - Historical Returns
Returns include dividend reinvestment.
1M
SARO
-0.78%
Winner
OSCR
+1.05%
3M
SARO
+2.35%
Winner
OSCR
+84.64%
6M
SARO
-18.04%
Winner
OSCR
+74.38%
1Y
SARO
-12.06%
Winner
OSCR
+88.01%
5Y(CAGR)
SARO
N/A
OSCR
+8.29%
Max(CAGR)
SARO
-10.96%
Winner
OSCR
-3.43%
SARO vs OSCR - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | SARO | OSCR |
|---|---|---|
| 2026 | -10.19% | +92.79% |
| 2025 | +16.87% | +6.05% |
| 2024 | -24.40% | +47.69% |
| 2023 | N/A | +271.95% |
| 2022 | N/A | -69.74% |
| 2021 | N/A | -77.44% |
SARO vs OSCR Drawdown Comparison
The maximum drawdown for SARO was -32.58%, occurring on Apr 8, 2025. Recovery took 328 trading sessions.
The maximum drawdown for OSCR was -94.15%, occurring on Dec 21, 2022. This drawdown has not yet recovered.
The current SARO drawdown is -19.63%. The current OSCR drawdown is -21.51%.
| Rank | SARO | OSCR |
|---|---|---|
| #1 | -32.58% Oct 3, 2024 - Jan 27, 2026 | -94.15% Mar 10, 2021 - Dec 21, 2022 |
| #2 | -26.51% Jan 27, 2026 - Apr 23, 2026 | -10.92% Mar 3, 2021 - Mar 10, 2021 |
Correlation
Correlation between SARO and OSCR is 0.15 which considered as a very weak or no correlation - the stocks move independently of each other.
0.15
-101
Select Stocks to Compare
Popular: SARO vs SPYOSCR vs SPY
More Comparisons
Compare with similar stocks